User profiles for Anirban Basu

Anirban Basu

- Verified email at uw.edu - Cited by 18023

Anirban Basu

- Verified email at nbrc.ac.in - Cited by 9639

Anirban Basu

- Verified email at uohyd.ac.in - Cited by 1214

[HTML][HTML] Plant growth promoting rhizobacteria (PGPR) as green bioinoculants: recent developments, constraints, and prospects

A Basu, P Prasad, SN Das, S Kalam, RZ Sayyed… - Sustainability, 2021 - mdpi.com
The quest for enhancing agricultural yields due to increased pressure on food production
has inevitably led to the indiscriminate use of chemical fertilizers and other agrochemicals. …

Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling

JV Terza, A Basu, PJ Rathouz - Journal of health economics, 2008 - Elsevier
The paper focuses on two estimation methods that have been widely used to address
endogeneity in empirical research in health economics and health services research—two-stage …

[HTML][HTML] Recent understanding of soil acidobacteria and their ecological significance: a critical review

S Kalam, A Basu, I Ahmad, RZ Sayyed… - Frontiers in …, 2020 - frontiersin.org
Acidobacteria represents an underrepresented soil bacterial phylum whose members are
pervasive and copiously distributed across nearly all ecosystems. Acidobacterial sequences …

Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine

GD Sanders, PJ Neumann, A Basu, DW Brock… - Jama, 2016 - jamanetwork.com
Importance Since publication of the report by the Panel on Cost-Effectiveness in Health and
Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, …

Interleukin‐1: a master regulator of neuroinflammation

A Basu, JK Krady, SW Levison - Journal of neuroscience …, 2004 - Wiley Online Library
Interleukins 1α and 1β (IL‐1) are very potent signaling molecules that are expressed
normally at low levels, but are induced rapidly in response to local or peripheral insults. IL‐1 …

The effect of the Medicare Part D prescription benefit on drug utilization and expenditures

W Yin, A Basu, JX Zhang, A Rabbani… - Annals of internal …, 2008 - acpjournals.org
Background: Information about the effect of the Medicare Part D Prescription Drug Benefit on
drug utilization and expenditures is limited. Objective: To estimate changes in prescription …

Generalized modeling approaches to risk adjustment of skewed outcomes data

WG Manning, A Basu, J Mullahy - Journal of health economics, 2005 - Elsevier
There are two broad classes of models used to address the econometric problems caused
by skewness in data commonly encountered in health care applications: (1) transformation to …

Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy

JK Krady, A Basu, CM Allen, Y Xu, KF LaNoue… - Diabetes, 2005 - Am Diabetes Assoc
Diabetes leads to vascular leakage, glial dysfunction, and neuronal apoptosis within the
retina. The goal of the studies reported here was to determine the role that retinal microglial …

Projecting the future diabetes population size and related costs for the US

ES Huang, A Basu, M O'grady, JC Capretta - Diabetes care, 2009 - Am Diabetes Assoc
OBJECTIVE We developed a novel population-level model for projecting future direct spending
on diabetes. The model can be used in the federal budget process to estimate the cost …

[HTML][HTML] Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis

DD Kim, A Basu - Value in Health, 2016 - Elsevier
Background The prevalence of adult obesity exceeds 30% in the United States, posing a
significant public health concern as well as a substantial financial burden. Although the impact …